Literature DB >> 17416829

Diffusion tensor imaging-based fractional anisotropy quantification in the corticospinal tract of patients with amyotrophic lateral sclerosis using a probabilistic mixture model.

S K Schimrigk1, B Bellenberg, M Schlüter, B Stieltjes, R Drescher, J Rexilius, C Lukas, H K Hahn, H Przuntek, O Köster.   

Abstract

BACKGROUND AND
PURPOSE: In amyotrophic lateral sclerosis (ALS), fiber degeneration within the corticospinal tract (CST) can be quantified by diffusion tensor imaging (DTI) as an indirect marker of upper motor neuron involvement. A new method of measuring quantitative DTI parameters using a probabilistic mixture model for fiber tissue and background in the corticospinal tract of patients with ALS is evaluated.
MATERIALS AND METHODS: Axial echo-planar imaging (EPI) DTI datasets (6 gradient directions, 10 repetitions) were acquired for 10 patients and 20 healthy control subjects. The diffusion tensor was visualized in a multiplanar viewer using a unique color coding method. Pure fiber tissue inside a region is separated from background and mixture voxels using a probabilistic mixture model. This allows for a reduction of errors as a result of partial volume effects and measurement variability.
RESULTS: Fractional anisotropy (FA) was measured within the CST at levels ranging from internal capsule to pons. Mean coefficients of variation of intrarater, scan-rescan, and inter-rater reproducibility were 2.4%, 3.0%, and 5.7%, respectively. Optimal measurement positions along the CST with respect to minimum variability and maximum difference between patients and healthy subjects were identified in the caudal half of the internal capsule. Moreover, a negative correlation between the age-corrected FA and the disease duration but not the ALS Severity scale score was found.
CONCLUSION: The new software for fiber integrity quantification is suited to assess FA in the corticospinal tract with high reproducibility. Thus, this tool can be useful in future studies for monitoring disease status and potential treatment efficiency.

Entities:  

Mesh:

Year:  2007        PMID: 17416829      PMCID: PMC7977339     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  19 in total

1.  Diffusion-tensor MR imaging at 1.5 and 3.0 T: initial observations.

Authors:  S Hunsche; M E Moseley; P Stoeter; M Hedehus
Journal:  Radiology       Date:  2001-11       Impact factor: 11.105

2.  Diffusion tensor imaging and axonal tracking in the human brainstem.

Authors:  B Stieltjes; W E Kaufmann; P C van Zijl; K Fredericksen; G D Pearlson; M Solaiyappan; S Mori
Journal:  Neuroimage       Date:  2001-09       Impact factor: 6.556

Review 3.  Amyotrophic lateral sclerosis and primary lateral sclerosis: The role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers.

Authors:  Sumei Wang; Elias R Melhem
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

4.  Diffusion-tensor MR tractography of somatotopic organization of corticospinal tracts in the internal capsule: initial anatomic results in contradistinction to prior reports.

Authors:  Andrei I Holodny; Devang M Gor; Richard Watts; Philip H Gutin; Aziz M Ulug
Journal:  Radiology       Date:  2005-01-21       Impact factor: 11.105

5.  Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS.

Authors:  J M Graham; N Papadakis; J Evans; E Widjaja; C A J Romanowski; M N J Paley; L I Wallis; I D Wilkinson; P J Shaw; P D Griffiths
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

6.  Age-related alterations in white matter microstructure measured by diffusion tensor imaging.

Authors:  D H Salat; D S Tuch; D N Greve; A J W van der Kouwe; N D Hevelone; A K Zaleta; B R Rosen; B Fischl; S Corkin; H Diana Rosas; A M Dale
Journal:  Neurobiol Aging       Date:  2004-12-19       Impact factor: 4.673

7.  Amyotrophic lateral sclerosis: diffusion tensor tractography and voxel-based analysis.

Authors:  Osamu Abe; Haruyasu Yamada; Yoshitaka Masutani; Shigeki Aoki; Akira Kunimatsu; Hidenori Yamasue; Rinmei Fukuda; Kiyoto Kasai; Naoto Hayashi; Tomohiko Masumoto; Harushi Mori; Tsutomu Soma; Kuni Ohtomo
Journal:  NMR Biomed       Date:  2004-10       Impact factor: 4.044

8.  Amyotrophic lateral sclerosis severity scale.

Authors:  A D Hillel; R M Miller; K Yorkston; E McDonald; F H Norris; N Konikow
Journal:  Neuroepidemiology       Date:  1989       Impact factor: 3.282

9.  Diffusion tensor imaging in primary brain tumors: reproducible quantitative analysis of corpus callosum infiltration and contralateral involvement using a probabilistic mixture model.

Authors:  Bram Stieltjes; Mathias Schlüter; Bernd Didinger; Marc-André Weber; Horst K Hahn; Peter Parzer; Jan Rexilius; Olaf Konrad-Verse; Heinz-Otto Peitgen; Marco Essig
Journal:  Neuroimage       Date:  2006-02-14       Impact factor: 6.556

10.  Diffusion tensor imaging for long-term follow-up of corticospinal tract degeneration in amyotrophic lateral sclerosis.

Authors:  S Jacob; J Finsterbusch; J H Weishaupt; D Khorram-Sefat; J Frahm; H Ehrenreich
Journal:  Neuroradiology       Date:  2003-08-07       Impact factor: 2.804

View more
  25 in total

1.  Corticospinal tractography with morphological, functional and diffusion tensor MRI: a comparative study of four deterministic algorithms used in clinical routine.

Authors:  Romuald Seizeur; Nicolas Wiest-Daessle; Sylvain Prima; Camille Maumet; Jean-Christophe Ferre; Xavier Morandi
Journal:  Surg Radiol Anat       Date:  2012-03-18       Impact factor: 1.246

Review 2.  The present and the future of neuroimaging in amyotrophic lateral sclerosis.

Authors:  F Agosta; A Chiò; M Cosottini; N De Stefano; A Falini; M Mascalchi; M A Rocca; V Silani; G Tedeschi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-01       Impact factor: 3.825

3.  Diffusional kurtosis imaging of the developing brain.

Authors:  A Paydar; E Fieremans; J I Nwankwo; M Lazar; H D Sheth; V Adisetiyo; J A Helpern; J H Jensen; S S Milla
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-14       Impact factor: 3.825

4.  White matter pathology in ALS and lower motor neuron ALS variants: a diffusion tensor imaging study using tract-based spatial statistics.

Authors:  Johannes Prudlo; Charlotte Bißbort; Aenne Glass; Annette Grossmann; Karlheinz Hauenstein; Reiner Benecke; Stefan J Teipel
Journal:  J Neurol       Date:  2012-02-21       Impact factor: 4.849

5.  Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study.

Authors:  F Agosta; E Pagani; M Petrolini; D Caputo; M Perini; A Prelle; F Salvi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-15       Impact factor: 3.825

6.  The topography of brain microstructural damage in amyotrophic lateral sclerosis assessed using diffusion tensor MR imaging.

Authors:  E Canu; F Agosta; N Riva; S Sala; A Prelle; D Caputo; M Perini; G Comi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-16       Impact factor: 3.825

7.  Diagnostic accuracy using diffusion tensor imaging in the diagnosis of ALS: a meta-analysis.

Authors:  Bradley R Foerster; Ben A Dwamena; Myria Petrou; Ruth C Carlos; Brian C Callaghan; Martin G Pomper
Journal:  Acad Radiol       Date:  2012-06-28       Impact factor: 3.173

8.  Diffusion tensor imaging detects abnormalities in the corticospinal tracts of neonates with infantile Krabbe disease.

Authors:  M L Escolar; M D Poe; J K Smith; J H Gilmore; J Kurtzberg; W Lin; M Styner
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-22       Impact factor: 3.825

Review 9.  Biomarkers in amyotrophic lateral sclerosis: facts and future horizons.

Authors:  Pierre-François Pradat; Michel Dib
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

10.  Brain white matter diffusion tensor metrics from clinical 1.5T MRI distinguish between ALS phenotypes.

Authors:  Venkateswaran Rajagopalan; Guang H Yue; Erik P Pioro
Journal:  J Neurol       Date:  2013-07-18       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.